89 related articles for article (PubMed ID: 3425023)
1. [Initial experiences with the determination of neopterin in the urine of females with genital and breast tumors].
Bartel U; Rabe H; Schulz-Pinkus M
Zentralbl Gynakol; 1987; 109(20):1226-32. PubMed ID: 3425023
[TBL] [Abstract][Full Text] [Related]
2. [Value of neopterin as an oncologic laboratory parameter--observations in gynecologic tumors].
von Broen B; Kavungu P
Z Gesamte Inn Med; 1990 Apr; 45(8):223-5. PubMed ID: 2378135
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary neopterin in normal pregnant and non-pregnant women and in women with benign and malignant genital tract neoplasms.
Bichler A; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Wachter H
Arch Gynecol; 1983; 233(2):121-30. PubMed ID: 6882017
[TBL] [Abstract][Full Text] [Related]
4. [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)].
Wachter H; Hausen A; Grassmayr K
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1957-60. PubMed ID: 527945
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
[TBL] [Abstract][Full Text] [Related]
7. A research on the level of urine neopterin to see if it may provide a vital clue for a provisional diagnosis of breast cancer in menopausal women.
Bayram M; Bayram O; Boyunaga H; Ozer G
Maturitas; 2004 Aug; 48(4):432-7. PubMed ID: 15283936
[TBL] [Abstract][Full Text] [Related]
8. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases.
Hausen A; Bichler A; Fuchs D; Hetzel H; Reibnegger G; Wachter H
Cancer Detect Prev; 1985; 8(1-2):121-8. PubMed ID: 4064032
[TBL] [Abstract][Full Text] [Related]
9. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
Frick J; Aulitzky W; Fuchs D; Hausen A; Joos H; Reibnegger G; Wachter H
Urol Int; 1985; 40(3):155-9. PubMed ID: 3874460
[TBL] [Abstract][Full Text] [Related]
10. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
11. [Role of the immune parameter neopterin in adnexitis].
Marth C; Windbichler G; Fuchs D; Zeimet AG; Wachter H; Dapunt O
Zentralbl Gynakol; 1996; 118(3):164-8. PubMed ID: 8900606
[TBL] [Abstract][Full Text] [Related]
12. Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer.
Hetzel H; Bichler A; Fuchs D; Hausen A; Reibnegger G; Wachter H
Cancer Detect Prev; 1983; 6(1-2):263-6. PubMed ID: 6883385
[TBL] [Abstract][Full Text] [Related]
13. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
Schwarz-Roeger U; Petzoldt B; Waldschmidt R; Walker RP; Bauknecht T; Kiechle M
Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
[TBL] [Abstract][Full Text] [Related]
14. [Urinary neopterin: its value in the study of various neoplasms].
Mura P; Piriou A; Tallineau C; Reiss D
Ann Biol Clin (Paris); 1986; 44(5):505-10. PubMed ID: 3492947
[TBL] [Abstract][Full Text] [Related]
15. Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.
Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
[TBL] [Abstract][Full Text] [Related]
16. Neopterin in the diagnosis of disorders associated with immune system activation.
Melichar B; Lukes J; Malír F; Tichý M
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):149-55. PubMed ID: 8159911
[TBL] [Abstract][Full Text] [Related]
17. The significance of neopterin and biopterin concentrations at presentation in haematological malignancies.
Davies SV; Carter C; Williams MD; Pollock A; Leeming RJ
Clin Lab Haematol; 1992; 14(1):41-6. PubMed ID: 1600692
[TBL] [Abstract][Full Text] [Related]
18. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
[TBL] [Abstract][Full Text] [Related]
19. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
20. Improved HPLC determination of urinary neopterin.
Dewitte JD; Berthou F; Dreano Y; Floch HH
Biomed Chromatogr; 1987; 2(5):183-8. PubMed ID: 3333725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
